SHP099 HCl

For research use only.

Catalog No.S8278

26 publications

SHP099 HCl Chemical Structure

CAS No. 2200214-93-1

SHP099 is a highly potent, selective and orally bioavailable small-molecule SHP2 inhibitor with an IC50 value of 0.071 μM and shows no activity against SHP1.

Selleck's SHP099 HCl has been cited by 26 publications

Purity & Quality Control

Choose Selective phosphatase Inhibitors

Biological Activity

Description SHP099 is a highly potent, selective and orally bioavailable small-molecule SHP2 inhibitor with an IC50 value of 0.071 μM and shows no activity against SHP1.
SHP-2 [1]
(Cell-free assay)
0.07 μM
In vitro

SHP099 shows inhibition of cell proliferation (KYSE-520 model) with an IC50 of 1.4 μM. In both phosphatase and kinase panels, no biochemical inhibitory activity is evident, suggesting that the aminopyrazine series(SHP099) is quite selective for SHP2. Moreover, SHP099 shows high solubility (>0.5 mM in pH 6.8 buffer) and high permeability with no apparent efflux in Caco-2 cells[1]. SHP099 stabilizes SHP2 in an auto-inhibited conformation. SHP099 suppresses RAS-ERK signalling to inhibit the proliferation of receptor-tyrosine-kinase-driven human cancer cells in vitro. SHP099 only has modest activity against 5HT3 when profiled against a preclinical safety pharmacology panel representing 49 common adverse drug reaction targets. SHP099 shows no activity against SHP1, the closest homologue of SHP2 sharing 61% amino acid sequence identity, supporting its high degree of target selectivity. It inhibits p-ERK with an IC50 of ~0.25 μM in SHP2-dependent MDA-MB-468 and KYSE520 cells, but not in A2058 cells. No effect is observed on p-AKT levels across the same cells. SHP099 inhibits MAPK signalling and proliferation in RTK-dependent cells through direct on-target inhibition of SHP2[2].

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
MGH049-1A MX\GeY5kfGmxbjDhd5NigQ>? MnP0OUDPxE1? NG\GO4cyPCCmYYnz NFHQXHpCeyCjIIPpcodt\SCjZ3XueEwhW0iSMEm5JIhi\CCvaX7pcYFtKGWoZnXjeEBwdiClZXzsJJBzd2yrZnXyZZRqd25? M{XZUVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NUC1NFM{Lz5{OUWwOVA{OzxxYU6=
MGH073-2B NUnZc|hpTnWwY4Tpc44h[XO|YYm= NGTacnk2KM7:TR?= M4nTbFE1KGSjeYO= M1G0WmF{KGFic3nu[4xmKGGpZX70MEBUUFByOUmgbIFlKG2rbnntZYwh\W[oZXP0JI9vKGOnbHygdJJwdGmoZYLheIlwdg>? MXG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTVyNUCzN{c,Ojl3MEWwN|M9N2F-
MGH065-1B M4DF[mZ2dmO2aX;uJIF{e2G7 NXXmNXN5PSEQvF2= NF6yR4MyPCCmYYnz MV7Bd{BiKHOrbnfs[UBi\2WwdDygV2hRODl7IHjh[EBucW6rbXHsJIVn\mWldDDvckBk\WyuIIDyc4xq\mW{YYTpc44> M1vENVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NUC1NFM{Lz5{OUWwOVA{OzxxYU6=
MGH045-2A MorRSpVv[3Srb36gZZN{[Xl? MmLGOUDPxE1? MW[xOEBl[Xm| M1nBNGF{KGFic3nu[4xmKGGpZX70MEBUUFByOUmgbIFlKG2rbnntZYwh\W[oZXP0JI9vKGOnbHygdJJwdGmoZYLheIlwdg>? Ml:2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl3MEWwN|MoRjJ7NUC1NFM{RC:jPh?=
U2OS cells NGjIPYlHfW6ldHnvckBie3OjeR?= NHTwW5QxNCBzLDCzMEA3NCBzMjygNlUtKDVyIN88US=> NF7RVWZUUFByOUmgdoVlfWOnczDwSZJsKGyndnXsd{BqdiC5aXzkMZR6eGViVULPV{Bk\Wyucz6= MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODN5NUO4PEc,OzB|N{WzPFg9N2F-
KYSE-520 M4rzfnBzd2yrZnXyZZRqd25iYYPzZZk> NHHK[nI2KGSjeYO= MmC0bY5pcWKrdHnvckBw\iClZXzsJJBzd2yrZnXyZZRqd25id3n0bEBidiCLQ{WwJI9nKDFwNDFOwG0> M4DNZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5M{S3OlkzLz5{N{O0O|Y6OjxxYU6=
MOLM14 MnjMRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? M1nzOVMh\GG7cx?= NEDWSFJCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3PUG0yPCClZXzsd{Bi\nSncjCzJIRigXNiYomgR4VtdFSrdHXyMWdtdyCudX3pcoV{[2WwY3WgZZN{[XluIFnDOVAhRSByLkmg{txONg>? NYLzVppJRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkmwPFkzPTdpPkK5NFg6OjV5PD;hQi=>

... Click to View More Cell Line Experimental Data

Methods Test Index PMID
Western blot
pERK / Bcl-xL / p85 PARP; 

PubMed: 29568093     

Immunoblot analysis of cell lysates after 2 days of SHP099 treatment.

pMEK / MEK / pERK / Erk; 

PubMed: 30605687     

The same cell lines were treated with SHP (5 μM), and the pERK rebound was monitored for 24 hr by immunoblotting with the indicated antibodies.

EGFR / pEGFR / GAB1 / pSHP2 / GRB2 / SOS1; 

PubMed: 30605687     

HeLa cells were pretreated with either DMSO or SHP099 (SHP, 10 μM) for 1 hr before stimulation with epidermal growth factor (EGF, 10 ng/mL) for the indicated times. Cell lysates were either subjected to immunoprecipitation with a SHP2 antibody, followed by immunoblotting, or immunoblotted with the indicated antibodies.

29568093 30605687
Growth inhibition assay
Cell viability; 

PubMed: 29568093     

Growth inhibiting activity of SHP099 in the four SHP2 mutant cell lines. Cells were cultured in GM-CSF free medium with indicated concentrations of SHP099 and viable cells were measured on Day 5.

insulin receptor; 

PubMed: 30931927     

HepG2 cells expressing IR-GFP WT were starved, treated with the indicated inhibitors for 2 h, treated without or with 100 nM insulin for 20 min, and stained with anti-GFP (IR; green) and DAPI (blue). Scale bar, 5 µm.

In vivo SHP099 shows acceptable oral exposure (5 mg/kg PO, 565 μM/h) and bioavailability (46% F). SHP099 is a potent, selective, highly soluble, orally bioavailable, and efficacious SHP2 inhibitor exhibiting dose-dependent pathway inhibition and antitumor activity in xenograft models[1]. Orally administered SHP099 shows dose-dependent anti-tumour activity in the KYSE520 xenograft model and is well tolerated[2].


Cell Research:


- Collapse
  • Cell lines: KYSE-520 cells
  • Concentrations: 20, 6.6, 2.2, 0.74, 0.24, 0.08, and 0.027 μM
  • Incubation Time: 2 h
  • Method:

    KYSE-520 cells (30,000 cells/well) are grown in 96-well plate culture overnight and treated with SHP2 inhibitors at concentrations of 20, 6.6, 2.2, 0.74, 0.24, 0.08, and 0.027 μM for 2 h at 37 °C. Incubations are terminated by addition of 30 μL of lysis buffer supplied with the SureFire p-ERK assay kit.

    (Only for Reference)
Animal Research:


- Collapse
  • Animal Models: Nude mice (Tumor Xenograft)
  • Dosages: 10, 30, or 100 mg/kg qd
  • Administration: by oral gavage
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 77 mg/mL warmed (198.08 mM)
Water 2 mg/mL warmed (5.14 mM)
Ethanol Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 388.72


CAS No. 2200214-93-1
Storage powder
in solvent
Synonyms N/A
Smiles Cl.CC1(N)CCN(CC1)C2=CN=C(C(=N2)N)C3=CC=CC(=C3Cl)Cl

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and SDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field
Tags: buy SHP099 HCl | SHP099 HCl supplier | purchase SHP099 HCl | SHP099 HCl cost | SHP099 HCl manufacturer | order SHP099 HCl | SHP099 HCl distributor
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID